247 related articles for article (PubMed ID: 28118722)
21. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.
Hickey M; Saunders C; Partridge A; Santoro N; Joffe H; Stearns V
Ann Oncol; 2008 Oct; 19(10):1669-80. PubMed ID: 18522932
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hot flushes in breast and prostate cancer.
Adelson KB; Loprinzi CL; Hershman DL
Expert Opin Pharmacother; 2005 Jun; 6(7):1095-106. PubMed ID: 15957964
[TBL] [Abstract][Full Text] [Related]
23. [Hot flushes and breast cancer with positive hormone receptors: Mechanisms and management].
Cavadias I; Rouzier R; Lerebours F; Héquet D
Bull Cancer; 2020 Nov; 107(11):1171-1185. PubMed ID: 32988609
[TBL] [Abstract][Full Text] [Related]
24. [Breast Cancer - Specifics of Gynecological Care and Counseling].
Weinberger V; Zikán M
Klin Onkol; 2016; 29 Suppl 3():S7-15. PubMed ID: 28118719
[TBL] [Abstract][Full Text] [Related]
25. Managing vasomotor symptoms in women after cancer.
Pinkerton JV; Santen RJ
Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
[TBL] [Abstract][Full Text] [Related]
26. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
27. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
[TBL] [Abstract][Full Text] [Related]
28. Symptoms and treatment in cancer therapy-induced early menopause.
Boekhout AH; Beijnen JH; Schellens JH
Oncologist; 2006 Jun; 11(6):641-54. PubMed ID: 16794243
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.
Riemma G; Schiattarella A; La Verde M; Zarobbi G; Garzon S; Cucinella G; Calagna G; Labriola D; De Franciscis P
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480427
[No Abstract] [Full Text] [Related]
30. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
[TBL] [Abstract][Full Text] [Related]
31. Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
Hutton B; Yazdi F; Bordeleau L; Morgan S; Cameron C; Kanji S; Fergusson D; Tricco A; Straus S; Skidmore B; Hersi M; Pratt M; Mazzarello S; Brouwers M; Moher D; Clemons M
Syst Rev; 2015 Aug; 4():114. PubMed ID: 26307105
[TBL] [Abstract][Full Text] [Related]
32. Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites.
Jager NG; Koornstra RH; Vincent AD; van Schaik RH; Huitema AD; Korse TM; Schellens JH; Linn SC; Beijnen JH
BMC Cancer; 2013 Dec; 13():612. PubMed ID: 24373320
[TBL] [Abstract][Full Text] [Related]
33. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
Bertelli G; Venturini M; Del Mastro L; Bergaglio M; Sismondi P; Biglia N; Venturini S; Porcile G; Pronzato P; Costantini M; Rosso R
Ann Oncol; 2002 Jun; 13(6):883-8. PubMed ID: 12123333
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
35. Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.
Johns C; Seav SM; Dominick SA; Gorman JR; Li H; Natarajan L; Mao JJ; Irene Su H
Breast Cancer Res Treat; 2016 Apr; 156(3):415-426. PubMed ID: 27015968
[TBL] [Abstract][Full Text] [Related]
36. Hot flushes in breast cancer patients.
Mom CH; Buijs C; Willemse PH; Mourits MJ; de Vries EG
Crit Rev Oncol Hematol; 2006 Jan; 57(1):63-77. PubMed ID: 16343926
[TBL] [Abstract][Full Text] [Related]
37. The management of menopausal symptoms in breast cancer survivors: case-based approach.
Lammerink EA; de Bock GH; Schröder CP; Mourits MJ
Maturitas; 2012 Nov; 73(3):265-8. PubMed ID: 22883373
[TBL] [Abstract][Full Text] [Related]
38. Managing menopausal symptoms after cancer.
Szabo RA; Marino JL; Hickey M
Climacteric; 2019 Dec; 22(6):572-578. PubMed ID: 31433675
[TBL] [Abstract][Full Text] [Related]
39. Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.
Binkhorst L; Mathijssen RH; van Herk-Sukel MP; Bannink M; Jager A; Wiemer EA; van Gelder T
Breast Cancer Res Treat; 2013 Jun; 139(3):923-9. PubMed ID: 23760858
[TBL] [Abstract][Full Text] [Related]
40. Pilot evaluation of citalopram for the relief of hot flashes.
Barton DL; Loprinzi CL; Novotny P; Shanafelt T; Sloan J; Wahner-Roedler D; Rummans TA; Christensen B; Dakhill SR; Martin LS
J Support Oncol; 2003; 1(1):47-51. PubMed ID: 15352642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
